2002
DOI: 10.1191/0960327102ht289oa
|View full text |Cite
|
Sign up to set email alerts
|

Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero

Abstract: Keliximab is a human-cynomolgus monkey chimeric (Primatized) monoclonal antibody with specificity for human and chimpanzee CD4. As the preclinical safety assessment of biopharmaceuticals requires evaluation in pharmacologically responsive species, comprehensive toxicology studies, including reproductive toxicity, of this antibody were conducted in a human CD4 transgenic mouse model. The reproductive toxicology studies included a preand postnatal development study that incorporated immunotoxicological … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 15 publications
0
4
0
1
Order By: Relevance
“…One of the most important questions considered in the workshops was how to determine the most appropriate species and strains to model the developing human immune system. A workshop organized by ILSI HESI in 2001 considered the following animal models in a series of plenary presentations: mice (Landreth, 2002;Herzyk et al, 2002;Holladay and Blalock, 2002), rats (Smialowicz, 2002;Chapin, 2002), pigs (Rothkotter et al, 2002), dogs (Felsburg, 2002) and nonhuman primates (Hendrickx et al, 2002;Neubert et al, 2002), in addition to humans (Neubert et al, 2002;West, 2002). A subsequent panel discussion, with input from all participants, offered several important conclusions (Holsapple, 2002a).…”
Section: Introductionmentioning
confidence: 98%
“…One of the most important questions considered in the workshops was how to determine the most appropriate species and strains to model the developing human immune system. A workshop organized by ILSI HESI in 2001 considered the following animal models in a series of plenary presentations: mice (Landreth, 2002;Herzyk et al, 2002;Holladay and Blalock, 2002), rats (Smialowicz, 2002;Chapin, 2002), pigs (Rothkotter et al, 2002), dogs (Felsburg, 2002) and nonhuman primates (Hendrickx et al, 2002;Neubert et al, 2002), in addition to humans (Neubert et al, 2002;West, 2002). A subsequent panel discussion, with input from all participants, offered several important conclusions (Holsapple, 2002a).…”
Section: Introductionmentioning
confidence: 98%
“…Biochemical changes induced by prenatal insults that lead to physiological deficits of organ function may not always be accompanied by detectable anatomical abnormalities. Hence, in recent decades, considerable attention has been drawn to functional teratology, an extension of the investigation beyond morphological examinations to include the evaluations of functional integrity of organ systems (for examples, see Kavlock and Grabowski, 1983;Lau and Kavlock, 1994;Herzyk et al, 2002). Nonetheless, a majority of these works has focused primarily on the perinatal and early postnatal periods, and long-term follow-up studies are seldom available.…”
Section: Introductionmentioning
confidence: 98%
“…19 Gü-nümüze kadar IL-12p40 knock-out, IL-6 knock-out ve HuCD4 transgenik farelerin gelişme ve üreme toksikolojisi çalışmalarında başarıyla kullanıldığı belirtilmiştir. 19,[64][65][66] İyi çalışma şartlarına uygun laboratuvarlarda günümüze kadar juvenil toksikoloji araştırmala-rında genetiği değiştirilmiş hayvanların kullanıldı-ğına ilişkin bir çalışmaya rastlanmamıştır.…”
Section: Geneti̇ği̇ Deği̇şti̇ri̇lmi̇ş Hayvanlarin İlaç Güvenli̇ği̇nde Kullanimiunclassified